Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and ...
Hosted on MSN
CRDF: Colorectal cancer KOL event
Cardiff Oncology, Inc. (NASDAQ: CRDF) held a key opinion leader (KOL) event on March 25 th, 2026, coinciding with National Colorectal Cancer Awareness Month. The event featured two luminaries in the ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results